Skip to main content
Veterinary Medicines

Valbazen 100 mg/ml - Suspension zum Eingeben für Rinder

Authorised
  • Albendazole

Product identification

Medicine name:
Valbazen 100 mg/ml - Suspension zum Eingeben für Rinder
Active substance:
  • Albendazole
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Albendazole
    10.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        7
        day
      • Milk
        84
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC11
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Osterreich GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
  • Purna Pharmaceuticals
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00316
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 7/11/2023
Updated on: 13/01/2025

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 2/06/2021
Updated on: 13/01/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 14/09/2023
Updated on: 13/01/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."